7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Ventricular Tachycardia
Ventricular Tachycardia (VT) is an abnormal heart rhythm marked by a rapid and sustained heartbeat originating in the ventricles, the heart's lower chambers. This condition results in a disruption of the heart's normal electrical activity, leading to a significantly elevated heart rate. Ventricular Tachycardia poses a serious medical concern, as it can compromise the heart's ability to pump blood effectively, potentially leading to complications such as dizziness, fainting, or even cardiac arrest. While Ventricular Tachycardia is often associated with underlying heart conditions like coronary artery disease or structural abnormalities, it can also manifest in individuals with structurally normal hearts. The exact cause may vary, including scar tissue from a previous heart attack, genetic factors, or certain medications.
Arthur J Siegel
Massachusetts General Hospital, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Arthur J Siegel
Massachusetts General Hospital, United States
Yong Xiao Wang
Albany Medical Center, United States
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian FederationSubmit your abstract Today
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Young hearts at risk: Hidden cardiovascular damage and the role of social determinants of health among youth with type 1 diabetes in Kenya
Phoebe Wamalwa, Ministry of Health, Kenya